Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


No Link Found Between Various Insulins and Breast Cancer
Study examined short- to mid-term duration of use

TUESDAY, Sept. 3 (HealthDay News) -- Various types of insulins are not associated with breast cancer risk, according to a study published online Aug. 15 in Diabetes Care.

Lamiae Grimaldi-Bensouda, Ph.D., from LA-SER and the National Conservatory of Arts and Crafts in Paris, and colleagues examined the association between individual insulins (glargine, aspart, lispro and human insulin) and breast cancer in 775 incident cases of primary invasive or in situ carcinoma breast cancer in women with diabetes and 3,050 matched community controls without diabetes.

After a mean insulin exposure of 3.2 years, the researchers found that, after adjusting for various factors, the odds ratio of breast cancer was 1.04 for glargine, 1.23 for lispro, 0.95 for aspart, and 0.81 for human insulin. There were no differences between glargine and other types of insulins, and the results were unaffected by insulin dosage, duration of use, and tumor stage.

"This international study found no difference in the risk of developing breast cancer in patients with diabetes among the different types of insulin with short- to mid-term duration of use," Grimaldi-Bensouda and colleagues conclude.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2013 HealthDay. All rights reserved.

August 27, 2014

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

HTN Self-Management Beneficial in High-Risk Patients

Ban Indoor Use of E-Cigarettes, U.N. Health Agency Says

Vitamin D Deficiency Worsens Outcomes With B-Cell Lymphoma

Medicaid Office Visit Payment Tied to Cancer Screening Rates

Low Weight at Birth Ups Risk of Diabetes in Black Women

New Rules for Religious Objections to Health Care Law